Latest Insights on MRNA
The Secret to Investing Safely in Biotech August 13, 2021 Big Picture. Big Profits., Technology, U.S. Economy
Biotech is back — new vaccines, new technologies. It's certainly tempting for the average investor to try to stake a claim right now. But as enticing as those stories about lifesaving drugs and potential profits may seem, biotech investing is risky business. I learned a painful — but powerful — lesson myself that I'd like to share with you. In today’s video, you'll see that there is a better, safer way to play this biotech boom ... all while collecting enormous dividends.
Mr. Mojo Hyzon, Not So Fine Cytodyn-ing & Covered Calling Cards August 12, 2021 Great Stuff
Helluva Hydrogen Hullabaloo It’s that time again, Great Ones! To send away for the free brochure? To make bubbles with our spit? To make wildly inaccurate predictions about the stock market? No, you Animaniacs … though, that last one wounds me a bit. It’s time for Reader Feedback! Today is the day we dig through […]
Sanofi’s mRNA Play, The SolarEdge Of Greatness & Slinging Spiritual Opium August 3, 2021 Great Stuff
Do You Know The Way To Sanofi? Great Ones, the future of health care isn’t in the future … it’s already here. And we can thank COVID-19 for its early arrival. I’m talking about mRNA technology. You know … messenger ribonucleic acid? Did y’all just not take biology in high school? Here’s a quick refresher. […]
How to Turn Market Turmoil Into Profit Opportunities July 22, 2021 Trading Strategies, True Options Masters
Monday was a huge problem in the markets. But with the right information and a bit of gut instinct, you can turn any problem into profits... 
The No. 1 Health Care ETF for the Vaccine Race May 26, 2021 American Investor Today, News, U.S. Economy
(4-minute read) Vaccines are being distributed across the country. And it’s showing us exactly how far we’ve come in health care technology. Here’s one way to profit…MEET OUR EXPERTS
Director of Investment Research
Editor of Strategic Fortunes and three elite services
Investment Strategist
Research Analyst
Editor of Alpha Investor
Editor of One Trade and Precision Profits
Director of VIP Services
